chartexchange
EDTUTC-4 New York
Sign up
FeedbackDocs

IBRX261113P00006500
IBRX Nov 13 2026 6.50 Put
optionOPRA

EODOct 16, 2026
0.05USD-95.146%(-0.98)10Vol11OI
Loading…
Underlying
IBRX
Underlying Price
$8.48
Type
Put
Strike
6.5
Expiration
Nov 13, 2026
DTE
24d
Moneyness
OTM
Intrinsic
$0.00
IBRX 6.5 Put Across Expirations
ExpirationDTELastChangeVolOpen Int
Oct 23, 20263d$0.05-66.67%47
Oct 30, 202610d$0.05-85.71%518
Nov 6, 202617d——00
Nov 13, 202624d$0.05-95.15%1011
Nov 27, 202638d——00
IBRX Nearby Strikes · Nov 13, 2026
StrikeLastChangeVolOpen IntMoneyness
3.5 P——00OTM
4 P——00OTM
4.5 P——00OTM
5 P——00OTM
5.5 P——00OTM
6 P$0.20-20.00%115OTM
6.5 P$0.05-95.15%1011OTM
7 P$0.20-60.00%8001,099OTM
7.5 P$0.28-6.67%107OTM
8 P$0.75+114.29%13OTM
8.5 P$0.45-6.25%56ITM
9 P$0.75+25.00%4232ITM
9.5 P$1.14+26.67%2024ITM
IBRX Profile

immunitybio is a leading registration-stage immuno-oncology and infectious disease company activating both the innate (natural killer cell and macrophage) and adaptive (t cell) immune system. we are developing molecular and product platforms including n-803, aldoxorubicin, and a second-generation adenovirus vector, which are based upon our three key modalities of activating natural killer ('nk') and t cells, tumoricidal macrophages, and memory t cells.